Correlation of 99m Tc-MIBI brain spect (Functional index ratios) and survival after treatment failure in malignant glioma patients

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 3081-3085

  Beauchesne, P ^a,c   Soler, C ^b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b Centre d'Imagerie Nucleaire   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

99mTc MIBI Brain SPECT; Functional index ratios; Malignant gliomas; Survival time; Tumor recurrence

Indexed keywords

CARMUSTINE; CORTICOSTEROID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROSOUREA; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COLLIMATOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG UPTAKE; EVOLUTION; FATALITY; FEMALE; GLIOBLASTOMA; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOMOSCINTIGRAPHY; TREATMENT FAILURE; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; BRAIN TUMOR; CLINICAL TRIAL; GLIOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; SURVIVAL RATE;

ADULT; AGED; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SURVIVAL RATE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036708836     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Black P: Brain tumors (first part). N Eng J Med 21: 1471-1476, 1991. Brain tumors (second part). N Eng J Medb 22: 1555-1564, 1991.
2. Black P: Brain tumors (first part). N Eng J Med 21: 1471-1476, 1991. Brain tumors (second part). N Eng J Medb 22: 1555-1564, 1991.
3. Fine HA, Dear KBG, Loeffler JS, Black P and Canellos GP: Meta-analysis of radiotherapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993.
4. Prados MD and Levin V: Biology and treatment of malignant glioma. Semin Oncol 27: 1-10, 2000.
5. Carvalho P, Richard B, Schwartz B et al: Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77: 565-570, 1992.
6. Vertosick F, Selker R, Grosman S and Joyce JM: Correlation of thallium-201 single-photon emission computerized tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurg 34: 396-401, 1994.
7. Dierckx RA, Martin JJ, Dobbeleir A, Crob R, Neertens I and De Deyn PD: Sensitivity and specificity of thallium-201 single-photon emission computerized tomography in the functional detection and differential diagnosis of brain tumors. Eur J Nucl Med 21: 621-623, 1994.
8. Kim KT, Black KL, Marciano D et al: Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 31: 965-969, 1990.
9. Loberbouym M, Baram J, Feidel M, Herchergs A and Lieberman L: A prospective evaluation of thallium-201 single-photon emission computerized tomography for brain tumor burden. Int J Radiat Oncol Biol Phys 32: 249-255, 1995.
10. Moody EM and Hodes JE: Thallium-avid cerebral radiation necrosis. Clin Nucl Med 19: 611-613, 1994.
11. Namba H, Togawa T, Yui N et al: The effect of steroid on thallium-201 uptake by malignant gliomas. Eur J Nucl Med 23: 991-992, 1996.
12. Ricci M, Pantano P, Pierallini NI A et al: Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 23: 524-529, 1996.
13. Yoshll Y, Satou M, Yamamoto T et al: The role of thallium-201 single-photon emission computerized tomography in the investigation and characterisation of brain tumors in man and their response to treatment. Eur J Nucl Med 20: 39-45, 1996.
14. Black KL, Emeric T, Hoh C, Hawkins RA, Mazziotta J and Becker DP: Thallium 201 SPECT and positron emission tomography equal predictions of glioma grade and recurrence. Neurol Res 16: 93-96, 1994.
15. Kahn D, Folett KA, Bushnell DL et al: Diagnosis of recurrent brain tumor: value of 201-TI SPECT vs 18F-Fluorodeoxyglucose PET. AJR 163: 1459-1465, 1994.
16. Baillet G, Albuquerque L, Chen Q, Poisson M and Delattre JY: Evaluation of single-photon emission computerized tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21: 1061-1066, 1994.
17. Bagni B, Pinna L, Tamarozzi R et al: SPECT imaging of intracranial tumors with 99mTc-sestamibi. Nucl Med Comm 16: 258-264, 1995.
18. Maffioli L, Gasparini M, Chiti A et al: Clinical role of technetium-99m sestamibi single-photon emission computerized tomography in evaluating pretreated patients with brain tumors. Eur J Nucl Med 23: 308-311, 1996.
19. O'Tuama LA, Treves S, Lararin et al: Thallium-201 versus technetium-99m MIBI SPECT in evaluation of childhood brain tumors. J Nucl Med 34: 1045-1051, 1993.
20. O'Tuama L, Packard A and Treves S: SPECT imaging of pediatric brain tumors with hexakis (2-methoxyisobutylisonitrile) technetium-99m. J Nucl Med 31: 2040-2041, 1990.
21. Andrews DW, Das R, Kim S, Zhang J and Curtis M: Technetium-MIBI as a glioma imaging agent for the assessement of multi-drug resistance. Neurosurg 40: 1323-1334, 1997.
22. Park CH, Kim KM and Zhang J: Tc-99m MIBI brain SPECT in the diagnosis of recurrent gliomas. Clin Nucl Med 19: 57-58, 1994.
23. Kao CH, Wang SJ and Liu TJ: The use of technetium - 99m MIBI breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994.
24. Khalkhali I, Mena I and Diggles L: Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium - 99m sestamibi. Eur J Nucl Med 21: 357-362, 1994.
25. Matsui R, Komori T, Narabayashi I, et al: Tc 99m - sestamibi uptake by malignant lymphoma and slow washout. Clin Nucl Med 20: 352-356, 1995.
26. Perrot JL, Soler C, Tiffet O et al: Detection of malignant melanoma metatstasis with 99m Tc-Sestamibi SPECT during follow-up of malignant melanoma in 17 patients. Eur J Dermatol 6: 505-508, 1996.
27. Soler C, Beauchesne P, Maatou-Gui K et al: Technetium-99m sestamibi single photon emission tomography for detection of recurrent gliomas after radiation therapyip. Eur J Nucl Med 25: 1649-1657, 1998.
28. Chiu ML, Kronauge JF, Piwnica-Worms D and Maatougui K: Effects of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium-99m in cultured mouse fibroblasts. J Nucl Med 31: 1646-1653, 1990.
29. Delmon-Moingeon LI, Piwnica-Worms D, Van Den Abbeele AD, Holman BL, Davison A and Jones AG: Uptake of the cation hexakis (2-methoxyisobutylisonitrile) technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50: 2198-2202, 1990.
30. Schwartz RB, Holman BL, Polak JF et al: Dual isotope single photon emission computerized tomography scanning in patient with glioblastoma multiform: association with patient survival and histopathological characteristic of tumor after high dose radiotherapy. J Neurosurg 89: 60-68, 1998.
31. Zhang JJ, Kim SM and Andrews DW: Tumor concentration index compared with maximum tumor index in the evaluation of recurrent brain tumor correlation with clinical outcome. Radiology 201: 331-338, 1996.
32. Kosuda S, Fujii H, Aoki S et al: Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 30: 1201-1206, 1994.
33. Schwartz RB, Carvalho PA, Alexander E III, Loeffler JS, Folkerth R and Holman BL: Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201 TI and 99m Tc-HMPAO. AJNR 2:1187-1192, 1991.
34. Cordobes M, Starzec A, Delmon-Moingeon L et al: Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with gene expression. J Nucl Med 37: 1784-1789, 1996.
35. Kostakoglu L, Elahi N, Kiratli P et al: Clinical validation of the influence of P- glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. J Nucl Med 38:1003-1008, 1997.
36. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC and Vilcoq J: Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein, overexpression. Eur J Nucl Med 23: 980-986, 1996.